Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Interesting times for Tetra

<< Previous

Bullboard Posts

Next >>

Comment by NSX001on Oct 20, 2022 10:41am

120 Views

Post# 35036174

RE:Interesting times for Tetra

Hi Davesnothere,

I know somebody's been selling/liquidating there millions of shares over the last few days, but who is buying these millions of shares?

It would be nice to know if someone in management is picking up some of those really cheap shares. If they were, then it would be a confidence boost for the company.

The last SEDAR relese did not paint a very good picture for the companies future. The company desperatly needs money just to makes regular payments, besides paying off the loan that's coming up.

I dread logging on to the stock market every day, afraid to see a really bad bad news release from the company.

NSX001

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing